110 related articles for article (PubMed ID: 6246714)
1. Human T cell response to Herpes simplex virus antigen in vitro.
Berle EJ; Thorsby E
Acta Pathol Microbiol Scand C; 1980 Feb; 88(1):31-7. PubMed ID: 6246714
[TBL] [Abstract][Full Text] [Related]
2. Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus.
Braathen LR; Berle E; Mobech-Hanssen U; Thorsby E
Acta Derm Venereol; 1980; 60(5):381-7. PubMed ID: 6162307
[TBL] [Abstract][Full Text] [Related]
3. The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D.
Berle EJ; Thorsby E
Clin Exp Immunol; 1980 Mar; 39(3):668-75. PubMed ID: 6247109
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis.
Cunningham AL; Nelson PA; Fathman CG; Merigan TC
J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967
[TBL] [Abstract][Full Text] [Related]
6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
7. Role of macrophage D-region antigens and T-lymphocyte differentiation antigens in induction of gamma interferon.
Cunningham AL; Basham TY; Para MF; Merigan TC
J Interferon Res; 1985; 5(3):477-91. PubMed ID: 2997338
[TBL] [Abstract][Full Text] [Related]
8. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.
Valle MJ; Bobrove AM; Strober S; Merigan TC
J Immunol; 1975 Jan; 114(1 Pt 2):435-41. PubMed ID: 46881
[TBL] [Abstract][Full Text] [Related]
9. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
[TBL] [Abstract][Full Text] [Related]
10. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
Braathen LR; Thorsby E
Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
[TBL] [Abstract][Full Text] [Related]
11. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
12. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
13. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.
Shillitoe EJ; Tarro G; Lehner T
Oncology; 1976; 33(4):192-5. PubMed ID: 65753
[TBL] [Abstract][Full Text] [Related]
15. Both DR and MT class II HLA molecules may restrict proliferative T-lymphocyte responses to antigen.
Berle EJ; Thorsby E
Scand J Immunol; 1982 Dec; 16(6):543-7. PubMed ID: 6186016
[TBL] [Abstract][Full Text] [Related]
16. [The leukocyte migration inhibition test (LMIT) in recurrent herpes simplex labialis. Comparison of the results of treatment with BCG and Levamisole (author's transl)].
Jarisch R; Sandor I; Cerni C
Arch Dermatol Res; 1979 May; 265(1):15-22. PubMed ID: 224827
[TBL] [Abstract][Full Text] [Related]
17. Murine epidermal antigen-presenting cells in primary and secondary T-cell proliferative responses to herpes simplex virus in vitro.
Williams NA; Hill TJ; Hooper DC
Immunology; 1991 Jan; 72(1):34-9. PubMed ID: 1847693
[TBL] [Abstract][Full Text] [Related]
18. Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.
Wainberg MA; Portnoy JD; Clecner B; Hubschman S; Lagacé-Simard J; Rabinovitch N; Remer Z; Mendelson J
J Infect Dis; 1985 Sep; 152(3):441-8. PubMed ID: 2993440
[TBL] [Abstract][Full Text] [Related]
19. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
20. HLA-D/DR restriction of proliferative T cell responses to antigen. Enrichment of antigen-specific T cell blasts and evidence of preferential HLA-D/DR restriction.
Berle EJ; Thoresen AB; Thorsby E
Tissue Antigens; 1982 Nov; 20(5):380-8. PubMed ID: 6186050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
